We used Sindbis virus, an alphavirus, as a model to study the evolution of the recognition of viral cis-acting sequences. During the life cycle of alphaviruses, a full-length minus-strand RNA is made and serves as a template for both genomic RNA replication and subgenomic mRNA transcription. Transcription initiates at an internal promoter site, the junction sequence, to produce a subgenomic mRNA. The junction sequences of alphaviruses are highly conserved, but they do contain a number of base differences. These Sindbis virus (SIN) is a positive-strand RNA enveloped virus in the Alphavirus genus of the family Togaviridae. In the infected cell, the viral genome is translated to produce two polyproteins that are cleaved into four nonstructural proteins. The nonstructural proteins (perhaps in conjunction with host factors) use the genomic RNA as a template to synthesize a minus strand. This minus strand is in turn used as a template by the nonstructural proteins, and possible host factors, for replication and transcription. Replication produces a full-length genomic 49S RNA. Transcnption initiates at an internal site, the junction region, to produce a subgenomic 26S mRNA that is colinear with the 3' one-third of the genomic RNA and encodes the viral structural proteins.
Sindbis virus (SIN) is a positive-strand RNA enveloped virus in the Alphavirus genus of the family Togaviridae. In the infected cell, the viral genome is translated to produce two polyproteins that are cleaved into four nonstructural proteins. The nonstructural proteins (perhaps in conjunction with host factors) use the genomic RNA as a template to synthesize a minus strand. This minus strand is in turn used as a template by the nonstructural proteins, and possible host factors, for replication and transcription. Replication produces a full-length genomic 49S RNA. Transcnption initiates at an internal site, the junction region, to produce a subgenomic 26S mRNA that is colinear with the 3' one-third of the genomic RNA and encodes the viral structural proteins.
The junction region contains a conserved sequence extending from 19 nucleotides (nt) upstream to 5 nt downstream (-19/+5) of the transcription start site of the subgenomic mRNA. This conserved sequence was proposed to be the promoter for subgenomic RNA synthesis of the alphaviruses (37) . The junction sequence is not found in naturally occurring defective interfering (DI) genomes, but when it was cloned into a DI genome it produced a subgenomic RNA (28) . The DI genome-derived subgenomic RNA initiated at the same position as wild-type virus. Deletion mapping of * Corresponding author.
the junction region showed that the minimal sequences necessary for transcription of a DI genome-derived subgenomic RNA was -18 or -19 to +5, where + 1 is the start site (28) . This minimal sequence encompasses the conserved junction sequence (37) and functions properly in both DI genomes and SIN as a promoter, although it is less active than, for example, a -98/+14 promoter (28, 41) .
The promoter is probably recognized by viral nonstructural proteins, perhaps in conjunction with host factors. Indeed, all four of the nonstructural proteins, and possibly the polyprotein precursors, are candidate transcription factors. Both in vivo and in vitro evidence indicates that the nsP4 protein is at least part of the viral polymerase (1, 17) . Late in infection, the nsP34 fusion protein may be the polymerase for plus-strand synthesis (6, 19) . The nsP2 protein is suspected to be involved in transcription, since a temperature-sensitive mutation that maps in nsP2 alters the relative amounts of subgenomic mRNA versus genomic RNA produced in infected cells (18, 22, 45, 46) . The subgenomic mRNA, like the genomic RNA, has a 5' m7G cap, and a methyltransferase activity that might participate in cap methylation has been mapped to nsPl (32, 33, 34 (28) , and then extracted and precipitated (52) . The RNA was denatured with glyoxal and dimethyl sulfoxide and electrophoresed on 1% agarose gels (4). The gels were treated for fluorography (26) (Fig. 1A) . The inserted sequences (Fig. 1B) were either the SIN minimal -19/+5 promoter sequence (28) , the corresponding junction sequences (-19/+5) from other alphaviruses (5, 8, 23, 27, 37, 48, 51) , or a sequence from rubella virus (RUB) that resembles the SIN minimal promoter (12, 13) . A derivative, mpNO (Fig. 1B) , with no exogenous sequences was also made to serve as a negative control. Each SIN derivative was named according to the source of the junction sequence inserted (Fig. 1B) 30 h posttransfection. These virus stocks were then used for all experiments described here.
All of the viruses derived from the cDNA clones are expected to make a 5.25-kb mRNA that initiates at the normal SIN promoter. This mRNA is bicistronic, encoding the SIN virus structural proteins followed by the CAT sequences. If the inserted junction sequence is functional as a promoter, the virus is expected to make an additional subgenomnic mRNA that is 1.45 kb in length and encodes CAT. All viruses produced genomic RNA and structural protein mRNA of the expected sizes (Fig. 2) . Most viruses produced a detectable second subgenomic mRNA whose size was that expected for the CAT mRNA. To facilitate comparisons among the viruses, the amount of the CAT mRNA was normalized to the amount of the structural protein mRNA made by each virus (see Materials and Methods). It should be noted that these molar ratios (Table  1) are results from a 2-h labeling period and do not represent accumulated mRNA.
The SIN minimal promoter of the mpSIN virus gave a molar ratio of 0.12 of CAT mRNA relative to the structural protein mRNA (Table 1; Fig. 2) , suggesting that the minimal promoter was used about one-eighth as efficiently as the wild-type promoter. This is due to a combination of the relatively weaker strength of the minimal promoter and a context effect (41) . The virus that lacks a minimal promoter, mpNO, gave an apparent mRNA molar ratio of 0.04, which is defined as the background. The junction sequence from RRV gave the most CAT mRNA. Remarkably, it was about twofold stronger than the SIN minimal promoter. The junction sequence of MBV had a promoter strength comparable to that of SIN, while the ONN, EEE, VEE, and SFV junction sequences appeared to be 50 to 90% as active as the minimal promoter of SIN. The mRNA molar ratios of mpSFV-1 and mpRUB viruses were essentially like that of mpNO. The SFV-1 junction sequence (51) is identical to the sequence reported by Ou et al. (37) except that a U is replaced by a C at position -1. This single nucleotide change made the SFV-1 junction sequence much less active as a promoter than that of SFV. Initiation sites of mRNA transcribed from heterologous junction sequences. The initiation site for the mRNA produced from each junction sequence was mapped by primer extension. All but mpSFV-1 and mpRUB gave major bands of primer extension products that paralleled the amount of CAT mRNA produced by each virus. The pattern of the bands is similar to that of the primer extension products from the 26S mRNA of SIN (15) , and they are consistent with mRNA initiation at nucleotide position +1 (Fig. 3) . The bands at position -1 are due to reverse transcriptase copying the cap. The RRV, MBV, SFV, and SFV-1 extension products all gave extra bands centered at position -6 that do not correlate with the amount of CAT mRNA made by the corresponding viruses. These bands probably do not represent 5' ends of the CAT mRNA but are most likely reverse transcriptase artifacts caused by local sequence or structure. Consistent with this view, these junction sequences are identical from -2 to -19 (Fig. 1B) . Similarly, extension products from the mpRUB virus intracellular RNA are likely to be reverse transcriptase artifacts.
CAT expression with use of heterologous junction sequences as promoters. During evolution, the optimum promoter activity is determined, at least in part, by the amount of viral structural proteins needed for production of progeny virions. Therefore, it is important to measure the amount of protein that can be made when the heterologous junction sequences are used. The viruses were constructed to have the junction sequences upstream of the bacterial CAT gene (Fig. 1) . The accumulated CAT enzyme activities were measured at 5, 7, and 9 h postinfection. The mpRRV virus gave the highest levels of CAT expression, from 2.0-to 2.7-fold higher than the levels produced by mpSIN (Fig. 4) . The mpSIN, mp-MBV, and mpEEE viruses expressed comparable amounts of CAT. Their CAT expression is comparable to or slightly higher (at 9 h) than that of the mpONN, mpSFV, and mpVEE viruses. The ONN and ONN* junction sequences differ only at position -19 (Fig. 1B) and they gave similar CAT expression (results not show). The mpSFV-1 and mpRUB viruses gave almost a 100-fold lower CAT expression than did mpSIN. The very low levels of CAT expressed by mpNO, which has no second pro- moter, could be due to a small amount of translational reinitiation or internal initiation of the bicistronic structural protein mRNA. It could also be due to internal cleavage of the structural protein mRNA to produce translatable CAT mRNA. Neutral and up mutations. Relative to the SIN junction sequence, the MBV junction sequence has G-for-A substitutions at positions -18 and -9 (Fig. 1B) . Since mpSIN and mpMBV gave similar amounts of CAT subgenomic mRNA and CAT expression, these two substitutions do not appreciably affect promoter recognition by the SIN-derived transcription factors. In combination, the changes are therefore neutral mutations. The same substitutions are present in the RRV junction sequence, yet it gave higher levels of CAT subgenomic mRNA and CAT expression. The RRV junction sequence has an additional difference, U at position +5 (U+5), compared with SIN and MBV that might be responsible for its enhanced promoter strength. We constructed a hybrid junction sequence called SNRV that is identical to the SIN junction sequence except for having U+5 (Fig. 1B) . By RNA analysis, the SNRV junction sequence was 1.5-fold stronger as a promoter than the SIN minimal promoter (Table 1 ). In another series of experiments, the mpSNRV virus also gave CAT expression at 5, 7, and 9 h postinfection that was similar to that of the mpRRV virus and higher than that of mpSIN and mpMBV (Table 2) . Thus, U+5 is an up mutation for SIN.
DISCUSSION
Use of heterologous junction sequences as promoters by SIN. The heterologous junction sequences, other than that of SFV-1 and RUB, are recognized relatively efficiently by SIN. The results show that they have similar promoter strengths, and there is less than a 10-fold difference in the amount of CAT enzyme produced when they are used as promoters (Fig. 4) (28) .
The junction sequence of SFV-1 and the RUB sequence were very weak promoters for SIN. The low efficiency of the SFV-1 junction sequence is interesting. It differs from the SFV junction sequence reported by Ou et al. (37) only in having C at the -1 position (51). The same U-to-C-1 mutation in a minimal SIN virus promoter resulted in low promoter activity (40) . Barring trivial possibilities, and if promoter recognition by SFV is similar to that of SIN, the stock of SFV characterized by Takkinen (51) is potentially quite interesting: it might harbor an unsuspected mutation that suppresses the C-1 mutation. The RUB sequence is used poorly by SIN. Although it resembles the conserved SIN junction sequence (13 identities out of 24 nt [12, 13] ), the RUB subgenomic mRNA initiates 17 nt downstream of the sequence (13) . Whether the RUB sequence is part of the RUB promoter is yet to be determined.
The promoter activity of the heterologous minimal junction sequences were measured in BHK cells. Their activities in other cell types such as avian and mosquito cells are yet to be determined. For example, some of the nucleotide differences in the junction sequences could be due to selection for optimal promoter activity in specific hosts cells (7) . The minimal promoter of SIN is the shortest sequence that is still active as a promoter (28) . It is about sixfold less active than a longer promoter, e.g., -98/+14 (28, 41 (40) . The alternate explanation is that most of the random mutations that occurred in the junction sequences were deleterious and were eliminated during evolution; those remaining constitute a functionally selected subset of all possible changes. Some of the changes might have been deleterious because they alter nsP4: the promoter overlaps the coding sequences for nsP4. However, the carboxyl terminus of nsP4 is not very strongly conserved. For example, the coding sequences for nsP4 of the New World viruses terminate at position -8, yet they all have seven invariant nucleotides immediately after the termination codon (Fig. 1B) (38) . Similarly, the 3' end of brome mosaic virus can functionally replace the 3' end of tobacco mosaic virus for replication mediated by tobacco mosaic virus replication proteins (21) . We believe that in general the viral cis-acting RNA sequences and their cognate viral proteins are subjected to mutual constraints from divergence: the cis-acting sequence and the cognate binding site cannot change independently. Consistent with this view is the ubiquitous occurrence of conserved, probably cis-acting sequences in each family of RNA viruses. They are found at the termini of the genomic RNA, presumably recognized for replication; in internal positions coincident with transcription initiation/termination; and at sites recognized during packaging of the genomic RNA (see, e.g., references 9, 44, 49, and 50). The conservation of these sequences is remarkable: they are frequently more conserved than the protein-coding sequences. For example, while the sequences coding for SIN and SFV nsP4 (probably the viral polymerase [1] ) are 65% homologous, the junction sequences are 83% homologous (the junction sequences are 71 to 92% homologous among the alphaviruses). Although the cis-acting roles of the conserved sequences of many viruses are yet to be demonstrated, their conservation despite sequence divergence elsewhere in the genome argues strongly for their functional importance.
Implications for antiviral drug design. Viral recognition of cis-acting sequences for replication, transcription, and packaging are obviously central aspects of the viral life cycle, and these sequences should be excellent targets for inhibition by antiviral drugs. Virus growth is inhibited when these processes are subjected to interference, e.g., by mutations in the cis-acting sequences (2, 10, 11, 15, 24, 31, 35, 36, 42) . More relevant to drug design, virus growth can be inhibited when recognition of cis-acting sequences is inhibited in trans. Inhibition has been obtained in the presence of antisense RNA (39) or with an excess of competing wild-type (50) or mutant (42) cis-acting sequences expressed in isolation or as part of DI genomes (29) or satellite RNA (e.g., reference 20). Our results as well as results with other viruses (42, 50) suggest that inhibiting the recognition of cis-acting sequences is a general approach for inhibiting virus growth. Since the cis-acting sequences are conserved, it may be difficult for the virus to mutate to drug resistance.
Also, since the cis-acting sequences are recognized at least in part by viral proteins, it may be possible to design drugs that inhibit the recognition without undesirable effects on host processes. Furthermore, our results suggest that broadspectrum drugs can be designed to inhibit a given virus that is effective also against closely related viruses.
